MARIA CARMEN
MONTESINOS MEZQUITA
TITULAR DE UNIVERSIDAD
Publicacions (66) Publicacions de MARIA CARMEN MONTESINOS MEZQUITA
2024
-
Adenosine A2B receptor agonist improves epidermal barrier integrity in a murine model of epidermal hyperplasia
Biomedicine and Pharmacotherapy, Vol. 173
-
Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model
Drug Delivery and Translational Research
-
Osteostatin Mitigates Gouty Arthritis through the Inhibition of Caspase-1 Activation and Upregulation of Nrf2 Expression
International Journal of Molecular Sciences, Vol. 25, Núm. 5
-
Trends in Scientific Production on Pharmaceutical Follow-up and the Dader Method
Pharmacy Practice, Vol. 22, Núm. 1
2023
-
Evolución de la producción científica sobre el seguimiento farmacoterapéutico y el método Dáder
Ars pharmaceutica, Vol. 64, Núm. 1, pp. 49-49
2021
-
Activation of the constitutive androstane receptor inhibits leukocyte adhesiveness to dysfunctional endothelium
International Journal of Molecular Sciences, Vol. 22, Núm. 17
-
Annexin A2-Mediated Plasminogen Activation in Endothelial Cells Contributes to the Proangiogenic Effect of Adenosine A2A Receptors
Frontiers in Pharmacology, Vol. 12
-
Cyanocobalamin ultraflexible lipid vesicles: Characterization and in vitro evaluation of drug-skin depth profiles
Pharmaceutics, Vol. 13, Núm. 3
-
El inglés como medio de instrucción (EMI) utilizado en el grupo de alto rendimiento académico en el grado de farmacia de la universidad de valencia
Docencia, ciencia y humanidades: hacia una enseñanza integral en la universidad del siglo XXI (Dykinson), pp. 1370-1387
-
Elaboración de documentos multimedia sobre noticias farmacológicas como recurso docente
Docencia, ciencia y humanidades: hacia una enseñanza integral en la universidad del siglo XXI (Dykinson), pp. 1354-1369
-
Elaboración de documentos multimedia sobre noticias farmacológicas como recurso docente
Universidad, innovación e investigación ante el horizonte 2030 (Egregius)
-
English as a Medium of Instruction (EMI) used in the high academic performance group in the Degree in Pharmacy at the University of Valencia
Universidad, innovación e investigación ante el horizonte 2030 (Egregius)
2020
-
Improved effectiveness from individualized dosing of self-administered biologics for the treatment of moderate-to-severe psoriasis: a 5-year retrospective chart review from a Spanish University Hospital
Journal of Dermatological Treatment, Vol. 31, Núm. 4, pp. 370-377
-
Microneedle‐based delivery: An overview of current applications and trends
Pharmaceutics, Vol. 12, Núm. 6, pp. 1-28
2019
-
Defective induction of COX-2 expression by psoriatic fibroblasts promotes pro-inflammatory activation of macrophages
Frontiers in Immunology, Vol. 10, Núm. MAR
2017
-
Adenosine A2A and A2B Receptors Differentially Modulate Keratinocyte Proliferation: Possible Deregulation in Psoriatic Epidermis
Journal of Investigative Dermatology, Vol. 137, Núm. 1, pp. 123-131
2016
-
Medicinal Plants and Natural Products as Potential Sources for Antiparkinson Drugs
Planta Medica, Vol. 82, Núm. 11-12, pp. 942-951
-
Methodological Approach to Use Fresh and Cryopreserved Vessels as Tools to Analyze Pharmacological Modulation of the Angiogenic Growth
Journal of Cardiovascular Pharmacology, Vol. 68, Núm. 3, pp. 230-240
2015
-
Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors
Arthritis Research and Therapy, Vol. 17, Núm. 1
-
Decreased SAPK/JNK signalling affects cytokine release and STAT3 activation in psoriatic fibroblasts
Experimental Dermatology